| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.fabinolife.com | |
| Market Cap | 6.30 Cr. | |
| Enterprise Value(EV) | 6.54 Cr. | 2021-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.23 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 131.25 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 30.55 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 21.63 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 1.39 | Calculated using Price: 30.00 |
| Dividend Yield | 0.00 | Period Ending 2021-03 |
| No. of Shares Subscribed | 0.21 Cr. | 2,100,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness focused consumer products. The company's core business is marketing of pharmaceutical formulation & products in domestic market through own distribution network and sales force under own brand name, getting its ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc. | ||
| 1 Day |
|
|
| 1 Week |
|
-11.24% |
| 1 Month |
|
+15.38% |
| 3 Month |
|
+20.0% |
| 6 Month |
|
+2.39% |
| 1 Year |
|
|
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 0.02 | 10.80 | 3.06 | |
| Return on Capital Employed (%) | 9.44 | 12.36 | 2.92 | |
| Return on Assets (%) | 0.00 | 1.14 | 1.04 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Shh. Funds | 1 | 1 | 1 | |
| Non Curr. Liab. | 0 | 1 | 0 | |
| Curr. Liab. | 8 | 2 | 1 | |
| Minority Int. | ||||
| Equity & Liab. | 9 | 4 | 2 | |
| Non Curr. Assets | 1 | 1 | 0 | |
| Curr. Assets | 8 | 3 | 2 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 9 | 4 | 2 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Net Sales | 3 | 8 | 3 | |
| Other Income | ||||
| Total Income | 3 | 8 | 3 | |
| Total Expenditure | -2 | -7 | -3 | |
| PBIDT | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | |
| Taxation | 0 | 0 | ||
| Exceptional Items | ||||
| PAT | 0 | 0 | ||
| Adjusted EPS | 5 | 0 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 2 | 0 | |
| Cash Fr. Inv. | 0 | 0 | ||
| Cash Fr. Finan. | 0 | -2 | 0 | |
| Net Change | 0 | 0 | ||
| Cash & Cash Eqvt | 0 | 0 | 0 |
|
Sat, 24 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Scrutinizers Report on e-voting and voting at the 11th Annual General Meeting (AGM) of the Company held on Thursday September 22 2022 is enclosed. |
|
Fri, 23 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 Annexed herewith is proceedings of 11th Annual General Meeting (AGM) of the Company held on 22 September 2022 at 105 1st Floor Barodia Tower Plot No 12 D Block Central Market Prashant Vihar New Delhi - 110085 as Annexure-I. |
|
Thu, 22 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 Annexed herewith is proceedings of 11th Annual General Meeting (AGM) of the Company held on 22 September 2022 at 105 1st Floor Barodia Tower Plot No 12 D Block Central Market Prashant Vihar New Delhi - 110085 as Annexure-I. |
| Mon, 26 Sep 2022 |
Opening at High
|
Opening at Low
|
Closing Below Previous Low
|
High Increase 1 Month
|
High Increase 3 Months
|
Equities
M.F.
Sectors